Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Thomas Jensen to Adult

This is a "connection" page, showing publications Thomas Jensen has written about Adult.

 
Connection Strength
 
 
 
0.059
 
  1. Jensen TJ, Haarbo J, Pehrson SM, Thomsen PE. Paroxysmal atrial fibrillation: ectopic atrial activity and prevalence of severely symptomatic patients. Pacing Clin Electrophysiol. 2003 Aug; 26(8):1668-74.
    View in: PubMed
    Score: 0.011
  2. Crowley MJ, McGuire DK, Alexopoulos AS, Jensen TJ, Rasmussen S, Saevereid HA, Verma S, Buse JB. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. Diabetes Care. 2020 09; 43(9):e108-e110.
    View in: PubMed
    Score: 0.009
  3. Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB. Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial. Diabetes Care. 2018 08; 41(8):1663-1671.
    View in: PubMed
    Score: 0.008
  4. Ahr?n B, Hirsch IB, Pieber TR, Mathieu C, G?mez-Peralta F, Hansen TK, Philotheou A, Birch S, Christiansen E, Jensen TJ, Buse JB. Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial. Diabetes Care. 2016 Oct; 39(10):1693-701.
    View in: PubMed
    Score: 0.007
  5. van den Brink W, Strang J, Gual A, S?rensen P, Jensen TJ, Mann K. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. Expert Opin Drug Saf. 2015 Apr; 14(4):495-504.
    View in: PubMed
    Score: 0.006
  6. Verhamme P, Pakola S, Jensen TJ, Berggren K, Sonesson E, Saint-Remy JM, Balchen T, Belmans A, Cahillane G, Stassen JM, Peerlinck K, Glazer S, Jacquemin M. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clin Ther. 2010 Jun; 32(6):1205-20.
    View in: PubMed
    Score: 0.004
  7. Nielsen AL, Larsen TM, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Astrup A. [The effect of tesofensine on body weight and body composition in obese subjects--secondary publication]. Ugeskr Laeger. 2009 Oct 05; 171(41):2974-7.
    View in: PubMed
    Score: 0.004
  8. Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 11 29; 372(9653):1906-1913.
    View in: PubMed
    Score: 0.004
  9. Bloch Thomsen PE, Joergensen RM, Kanters JK, Jensen TJ, Haarbo J, Hagemann A, Vestergaard A, Saermark K. Phase 2 reentry in man. Heart Rhythm. 2005 Aug; 2(8):797-803.
    View in: PubMed
    Score: 0.003
  10. Deckert T, Yokoyama H, Mathiesen ER, R?nn B, Jensen TJ, Feldt-Rasmussen BF, Borch-Johnsen K, Jensen JS. [Microalbuminuria as predictor of atherosclerotic cardiovascular disease in IDDM]. Ugeskr Laeger. 1997 May 12; 159(20):3010-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)